2026 Charles S. Fuchs: Medicine Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Best Scientists	184	531	492	342	311	1001	122637
Medicine	190	257	234	172	154	1000	130010

Research.com Recognitions

2025 - Research.com Best Scientists Award
Member of the Association of American Physicians
Member of the Association of American Physicians
Member of the Association of American Physicians

Overview

Charles S. Fuchs is affiliated with Genentech in the United States and has a significant body of work in the field of Medicine, particularly focusing on Oncology. Their research spans multiple subfields, including Pulmonary and Respiratory Medicine, Surgery, Pathology and Forensic Medicine, and Physiology.

The scientist's main research topics include:

Gastric Cancer Management and Outcomes
Colorectal Cancer Treatments and Studies
Cancer Immunotherapy and Biomarkers
Pancreatic and Hepatic Oncology Research
Colorectal Cancer Screening and Detection
Nutritional Studies and Diet
Genetic factors in colorectal cancer

Charles S. Fuchs has contributed extensively to several high-impact journals. Frequent publication venues include:

Journal of Clinical Oncology
UNC Libraries
Annals of Oncology
Cancer Epidemiology Biomarkers & Prevention
JNCI Cancer Spectrum

Collaboration is a notable aspect of their research career. Frequent co-authors are:

Jeffrey A. Meyerhardt
Shuji Ogino
Edward L. Giovannucci
Kimmie Ng
Andrew T. Chan

Among their recent published papers are:

Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial, 2021, Gastric Cancer
Assessment of Pembrolizumab Therapy for the Treatment of Microsatellite Instability-High Gastric or Gastroesophageal Junction Cancer Among Patients in the KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Clinical Trials, 2021, JAMA Oncology
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer, 2020, JAMA Oncology
The Prognostic Role of Macrophage Polarization in the Colorectal Cancer Microenvironment, 2020, Cancer Immunology Research
First-Line Pembrolizumab/Placebo Plus Trastuzumab and Chemotherapy in Her2-Positive Advanced Gastric Cancer: KEYNOTE-811, 2020, Future Oncology

Charles S. Fuchs is recognized as a Member of the Association of American Physicians.

Best Publications

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial

Charles S Fuchs;Jiri Tomasek;Cho Jae Yong;Filip Dumitru

2609
Citations
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment

Aleksandar D. Kostic;Aleksandar D. Kostic;Eunyoung Chun;Lauren Robertson;Jonathan N. Glickman

2359
Citations
Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial

Charles S. Fuchs;Toshihiko Doi;Raymond W. Jang;Raymond W. Jang;Kei Muro

1631
Citations
Long-Term Colorectal-Cancer Incidence and Mortality after Lower Endoscopy

Reiko Nishihara;Kana Wu;Paul Lochhead;Teppei Morikawa

1561
Citations
Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer

Susan Bullman;Susan Bullman;Chandra S. Pedamallu;Chandra S. Pedamallu;Ewa Sicinska;Thomas E. Clancy

1485
Citations
Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

Edward Giovannucci;Yan Liu;Eric B. Rimm;Bruce W. Hollis

1380
Citations
Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

Kohei Shitara;Mustafa Özgüroğlu;Yung-Jue Bang;Maria Di Bartolomeo

1294
Citations
Randomized, Controlled Trial of Irinotecan Plus Infusional, Bolus, or Oral Fluoropyrimidines in First-Line Treatment of Metastatic Colorectal Cancer: Results From the BICC-C Study

Charles S. Fuchs;John Marshall;Edith Mitchell;Rafal Wierzbicki

1104
Citations
A Prospective Study of Family History and the Risk of Colorectal Cancer

Charles S. Fuchs;Edward L. Giovannucci;Graham A. Colditz;David J. Hunter

1101
Citations
Night-Shift Work and Risk of Colorectal Cancer in the Nurses’ Health Study

Eva S. Schernhammer;Francine Laden;Frank E. Speizer;Walter C. Willett

1070
Citations
Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.

Edward Giovannucci;Meir J. Stampfer;Graham A. Colditz;David J. Hunter

1070
Citations
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties

William G. Kaelin;Wilhelm Krek;William R. Sellers;James A. DeCaprio

1059
Citations
Physical Activity and Survival After Colorectal Cancer Diagnosis

Jeffrey A. Meyerhardt;Edward L. Giovannucci;Michelle D. Holmes;Andrew T. Chan

1042
Citations
Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.

Xiaoyun Liao;Paul Lochhead;Reiko Nishihara;Teppei Morikawa

1020
Citations
Alcohol consumption and mortality among women

C. S. Fuchs;M. J. Stampfer;G. A. Colditz;E. L. Giovannucci

1010
Citations
Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma

Marios Giannakis;Marios Giannakis;Marios Giannakis;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Xinmeng Jasmine Mu;Sachet A. Shukla;Sachet A. Shukla;Zhi Rong Qian

999
Citations
Methylenetetrahydrofolate Reductase Polymorphism, Dietary Interactions, and Risk of Colorectal Cancer

Jing Ma;Meir J. Stampfer;Edward Giovannucci;Carmen Artigas

992
Citations
Dietary Fiber and the Risk of Colorectal Cancer and Adenoma in Women

Charles S. Fuchs;Edward L. Giovannucci;Graham A. Colditz;David J. Hunter

950
Citations
Aspirin and the Risk of Colorectal Cancer in Relation to the Expression of COX-2

Andrew T Chan;Shuji Ogino;Charles S Fuchs

907
Citations
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer

Shuji Ogino;Katsuhiko Nosho;Gregory J Kirkner;Takako Kawasaki

901
Citations

Frequent Co-Authors

Shuji Ogino Brigham and Women's Hospital

Andrew T. Chan Harvard University

Jeffrey A. Meyerhardt Harvard University

Kana Wu Harvard University

Walter C. Willett Harvard University

Brian M. Wolpin Harvard University

Reiko Nishihara Harvard University

David J. Hunter Harvard University

Mingyang Song Harvard University

Meir J. Stampfer Harvard University

External Links

Wikipedia of Charles S. Fuchs Personal website of Charles S. Fuchs

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Pursuing a traditional medical degree in the USA is not the only option for those interested in healthcare careers. Many students now explore flexible online programs that lead to rewarding roles in the medical and health sectors.

For those looking to enter leadership roles in healthcare, a healthcare administration associate degree online can provide foundational skills for managing healthcare facilities or services. If you’re already a registered nurse, the asn to fnp bridge programs offer a direct pathway to become a Family Nurse Practitioner, expanding your clinical knowledge and practice scope.

Nutrition and dietetics is another fast-growing field. Earning an online dietitian degree prepares students for roles supporting patient health through food science and nutrition. Those aiming for advanced management positions in healthcare often pursue cahme-accredited online mha programs, ensuring quality and recognition.

These online degrees provide accessible, accredited routes into healthcare and related professions—ideal for career-changers, working adults, or anyone seeking flexible study options.